Pulmonary Fibrosis in the Time of COVID-19

Overview

Journal Arch Bronconeumol

Specialty Pulmonary Medicine

Date 2022 May 1

PMID 35491285

Authors

Ivette Buendia-Roldan

Claudia Valenzuela

Moises Selman

Affiliations

Soon will be listed here.

Citing Articles

[Telemedicine Guide FOR Patients on Home Respiratory Therapies (Tele-HRT)].

Diaz Lobato S, Spiaggi E, Vergara Lahuerta I, Martin Arechabala I, Ocana Alcobe E, Perez Sanz J Open Respir Arch. 2023; 4(4):100193.

PMID: 37496958 PMC: 10369600. DOI: 10.1016/j.opresp.2022.100193.

References

Nakshbandi G, Moor C, Wijsenbeek M . Home monitoring for patients with ILD and the COVID-19 pandemic. Lancet Respir Med. 2020; 8(12):1172-1174. PMC: 7567485. DOI: 10.1016/S2213-2600(20)30452-5. View

Zhang P, Li J, Liu H, Han N, Ju J, Kou Y . Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020; 8:8. PMC: 7018717. DOI: 10.1038/s41413-020-0084-5. View

Ouyang L, Gong J, Yu M . Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis. Int Immunopharmacol. 2021; 100:108145. PMC: 8450148. DOI: 10.1016/j.intimp.2021.108145. View

Smatti M, Cyprian F, Nasrallah G, Al Thani A, Almishal R, Yassine H . Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses. 2019; 11(8). PMC: 6723519. DOI: 10.3390/v11080762. View

Hui D, Joynt G, Wong K, Gomersall C, Li T, Antonio G . Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005; 60(5):401-9. PMC: 1758905. DOI: 10.1136/thx.2004.030205. View

Esposito A, Menon A, Ghosh A, Putman R, Fredenburgh L, El-Chemaly S . Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study. Am J Respir Crit Care Med. 2020; 202(12):1710-1713. PMC: 7737588. DOI: 10.1164/rccm.202006-2441LE. View

Vianello A, Guarnieri G, Braccioni F, Lococo S, Molena B, Cecchetto A . The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med. 2021; 60(3):307-316. DOI: 10.1515/cclm-2021-1021. View

Mongelli A, Barbi V, Gottardi Zamperla M, Atlante S, Forleo L, Nesta M . Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Int J Mol Sci. 2021; 22(11). PMC: 8201243. DOI: 10.3390/ijms22116151. View

Knight J, Caricchio R, Casanova J, Combes A, Diamond B, Fox S . The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021; 131(24. PMC: 8670833. DOI: 10.1172/JCI154886. View

10.

Moor C, Mostard R, Grutters J, Bresser P, Aerts J, Chavannes N . Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2020; 202(3):393-401. DOI: 10.1164/rccm.202002-0328OC. View

11.

Althobiani M, Alqahtani J, Hurst J, Russell A, Porter J . Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians. BMJ Open Respir Res. 2021; 8(1). PMC: 8718433. DOI: 10.1136/bmjresp-2021-001088. View

12.

Das K, Lee E, Singh R, Enani M, Al Dossari K, Gorkom K . Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017; 27(3):342-349. PMC: 5644332. DOI: 10.4103/ijri.IJRI_469_16. View

13.

Britto C, Brady V, Lee S, Dela Cruz C . Respiratory Viral Infections in Chronic Lung Diseases. Clin Chest Med. 2017; 38(1):87-96. PMC: 5679206. DOI: 10.1016/j.ccm.2016.11.014. View

14.

Lee H, Choi H, Yang B, Lee S, Park T, Park D . Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J. 2021; 58(6). PMC: 8061231. DOI: 10.1183/13993003.04125-2020. View

15.

Matthay M, Zemans R, Zimmerman G, Arabi Y, Beitler J, Mercat A . Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019; 5(1):18. PMC: 6709677. DOI: 10.1038/s41572-019-0069-0. View